Stockreport

Why Collegium Pharmaceutical (COLL) Is Down 7.4% After Reaffirming 2026 Revenue Guidance Despite Earnings Miss [Yahoo! Finance]

Collegium Pharmaceutical, Inc.  (COLL) 
Last collegium pharmaceutical, inc. earnings: 2/27 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.collegiumpharma.com
PDF a year earlier, alongside record revenues, strong growth from ADHD drug Jornay PM, and reaffirmed 2026 product revenue guidance of US$805 million to US$825 million. At [Read more]